ANNALS OF HEMATOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2165922, encodeId=c38b216592281, content=2023.10.08 submitted to journal 2023.10.10 with editor 三周了还是with editor，啥意思是忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4958136403, createdName=ms9000000199469997, createdTime=Tue Oct 31 15:44:15 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128572, encodeId=f10c21285e230, content=大修了两周了还没信…555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b09c5466252, createdName=ms7000000764732971, createdTime=Thu Apr 27 02:16:05 CST 2023, time=2023-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126114, encodeId=42b7212611423, content=偏重的研究方向：白血病 经验分享：最近给这个杂志审过几篇稿子，一般是如果超过两周不给审的话就停止邀请，换审稿人了，接受审稿之后每周都会发来提醒邮件的。大修的稿子会返回给审稿人看的。感觉还行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sat Apr 15 19:33:15 CST 2023, time=2023-04-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=)]

2023-10-31 ms9000000199469997 来自山西省

2023.10.08 submitted to journal
2023.10.10 with editor
三周了还是with editor，啥意思是忘了吗

25 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165922, encodeId=c38b216592281, content=2023.10.08 submitted to journal 2023.10.10 with editor 三周了还是with editor，啥意思是忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4958136403, createdName=ms9000000199469997, createdTime=Tue Oct 31 15:44:15 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128572, encodeId=f10c21285e230, content=大修了两周了还没信…555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b09c5466252, createdName=ms7000000764732971, createdTime=Thu Apr 27 02:16:05 CST 2023, time=2023-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126114, encodeId=42b7212611423, content=偏重的研究方向：白血病 经验分享：最近给这个杂志审过几篇稿子，一般是如果超过两周不给审的话就停止邀请，换审稿人了，接受审稿之后每周都会发来提醒邮件的。大修的稿子会返回给审稿人看的。感觉还行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sat Apr 15 19:33:15 CST 2023, time=2023-04-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=)]

2023-10-21 清清欢来自江西省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;血液病
经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted

63 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165922, encodeId=c38b216592281, content=2023.10.08 submitted to journal 2023.10.10 with editor 三周了还是with editor，啥意思是忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4958136403, createdName=ms9000000199469997, createdTime=Tue Oct 31 15:44:15 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128572, encodeId=f10c21285e230, content=大修了两周了还没信…555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b09c5466252, createdName=ms7000000764732971, createdTime=Thu Apr 27 02:16:05 CST 2023, time=2023-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126114, encodeId=42b7212611423, content=偏重的研究方向：白血病 经验分享：最近给这个杂志审过几篇稿子，一般是如果超过两周不给审的话就停止邀请，换审稿人了，接受审稿之后每周都会发来提醒邮件的。大修的稿子会返回给审稿人看的。感觉还行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sat Apr 15 19:33:15 CST 2023, time=2023-04-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=)]

2023-11-22 ms5000001791427926 来自黑龙江省

作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？

2 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165922, encodeId=c38b216592281, content=2023.10.08 submitted to journal 2023.10.10 with editor 三周了还是with editor，啥意思是忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4958136403, createdName=ms9000000199469997, createdTime=Tue Oct 31 15:44:15 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128572, encodeId=f10c21285e230, content=大修了两周了还没信…555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b09c5466252, createdName=ms7000000764732971, createdTime=Thu Apr 27 02:16:05 CST 2023, time=2023-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126114, encodeId=42b7212611423, content=偏重的研究方向：白血病 经验分享：最近给这个杂志审过几篇稿子，一般是如果超过两周不给审的话就停止邀请，换审稿人了，接受审稿之后每周都会发来提醒邮件的。大修的稿子会返回给审稿人看的。感觉还行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sat Apr 15 19:33:15 CST 2023, time=2023-04-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=)]

2022-09-24 wylj

审稿结束状态一周还没给意见，是不是凶多吉少啊

51 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165922, encodeId=c38b216592281, content=2023.10.08 submitted to journal 2023.10.10 with editor 三周了还是with editor，啥意思是忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4958136403, createdName=ms9000000199469997, createdTime=Tue Oct 31 15:44:15 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128572, encodeId=f10c21285e230, content=大修了两周了还没信…555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b09c5466252, createdName=ms7000000764732971, createdTime=Thu Apr 27 02:16:05 CST 2023, time=2023-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126114, encodeId=42b7212611423, content=偏重的研究方向：白血病 经验分享：最近给这个杂志审过几篇稿子，一般是如果超过两周不给审的话就停止邀请，换审稿人了，接受审稿之后每周都会发来提醒邮件的。大修的稿子会返回给审稿人看的。感觉还行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sat Apr 15 19:33:15 CST 2023, time=2023-04-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=)]

2023-03-19 ms9000000180277427

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：hematology
经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收

47 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165922, encodeId=c38b216592281, content=2023.10.08 submitted to journal 2023.10.10 with editor 三周了还是with editor，啥意思是忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4958136403, createdName=ms9000000199469997, createdTime=Tue Oct 31 15:44:15 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128572, encodeId=f10c21285e230, content=大修了两周了还没信…555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b09c5466252, createdName=ms7000000764732971, createdTime=Thu Apr 27 02:16:05 CST 2023, time=2023-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126114, encodeId=42b7212611423, content=偏重的研究方向：白血病 经验分享：最近给这个杂志审过几篇稿子，一般是如果超过两周不给审的话就停止邀请，换审稿人了，接受审稿之后每周都会发来提醒邮件的。大修的稿子会返回给审稿人看的。感觉还行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sat Apr 15 19:33:15 CST 2023, time=2023-04-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=)]

2022-02-23 ms8000001664151388

请问大家这个submitted to journal 的状态会持续多长时间？

188 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165922, encodeId=c38b216592281, content=2023.10.08 submitted to journal 2023.10.10 with editor 三周了还是with editor，啥意思是忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4958136403, createdName=ms9000000199469997, createdTime=Tue Oct 31 15:44:15 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128572, encodeId=f10c21285e230, content=大修了两周了还没信…555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b09c5466252, createdName=ms7000000764732971, createdTime=Thu Apr 27 02:16:05 CST 2023, time=2023-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126114, encodeId=42b7212611423, content=偏重的研究方向：白血病 经验分享：最近给这个杂志审过几篇稿子，一般是如果超过两周不给审的话就停止邀请，换审稿人了，接受审稿之后每周都会发来提醒邮件的。大修的稿子会返回给审稿人看的。感觉还行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sat Apr 15 19:33:15 CST 2023, time=2023-04-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=)]

2023-09-14 清清欢来自江西省

审稿速度:1.0
偏重的研究方向：hematology
经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165922, encodeId=c38b216592281, content=2023.10.08 submitted to journal 2023.10.10 with editor 三周了还是with editor，啥意思是忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4958136403, createdName=ms9000000199469997, createdTime=Tue Oct 31 15:44:15 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128572, encodeId=f10c21285e230, content=大修了两周了还没信…555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b09c5466252, createdName=ms7000000764732971, createdTime=Thu Apr 27 02:16:05 CST 2023, time=2023-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126114, encodeId=42b7212611423, content=偏重的研究方向：白血病 经验分享：最近给这个杂志审过几篇稿子，一般是如果超过两周不给审的话就停止邀请，换审稿人了，接受审稿之后每周都会发来提醒邮件的。大修的稿子会返回给审稿人看的。感觉还行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sat Apr 15 19:33:15 CST 2023, time=2023-04-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=)]

2023-04-27 ms7000000764732971 来自北京

大修了两周了还没信…555

31 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165922, encodeId=c38b216592281, content=2023.10.08 submitted to journal 2023.10.10 with editor 三周了还是with editor，啥意思是忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4958136403, createdName=ms9000000199469997, createdTime=Tue Oct 31 15:44:15 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128572, encodeId=f10c21285e230, content=大修了两周了还没信…555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b09c5466252, createdName=ms7000000764732971, createdTime=Thu Apr 27 02:16:05 CST 2023, time=2023-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126114, encodeId=42b7212611423, content=偏重的研究方向：白血病 经验分享：最近给这个杂志审过几篇稿子，一般是如果超过两周不给审的话就停止邀请，换审稿人了，接受审稿之后每周都会发来提醒邮件的。大修的稿子会返回给审稿人看的。感觉还行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sat Apr 15 19:33:15 CST 2023, time=2023-04-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=)]

2023-04-15 suguoqing.my265 来自吉林省

偏重的研究方向：白血病
经验分享：最近给这个杂志审过几篇稿子，一般是如果超过两周不给审的话就停止邀请，换审稿人了，接受审稿之后每周都会发来提醒邮件的。大修的稿子会返回给审稿人看的。感觉还行。

36 0

[GetPortalCommentsPageByObjectIdResponse(id=2165922, encodeId=c38b216592281, content=2023.10.08 submitted to journal 2023.10.10 with editor 三周了还是with editor，啥意思是忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4958136403, createdName=ms9000000199469997, createdTime=Tue Oct 31 15:44:15 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128572, encodeId=f10c21285e230, content=大修了两周了还没信…555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b09c5466252, createdName=ms7000000764732971, createdTime=Thu Apr 27 02:16:05 CST 2023, time=2023-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126114, encodeId=42b7212611423, content=偏重的研究方向：白血病 经验分享：最近给这个杂志审过几篇稿子，一般是如果超过两周不给审的话就停止邀请，换审稿人了，接受审稿之后每周都会发来提醒邮件的。大修的稿子会返回给审稿人看的。感觉还行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sat Apr 15 19:33:15 CST 2023, time=2023-04-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=)]

2023-04-13 凶巴巴恰北北怪兽

2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气

33 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务